Grants and Contributions:
Title:
Development and scale-up of messenger RNA (mRNA) production, purification and encapsulation processes.
Agreement Number:
1007835
Agreement Value:
$410,000.00
Agreement Date:
Jul 3, 2023 - Mar 31, 2025
Description:
This project aims to develop, optimize and scale-up processes for the production and purification of mRNA and lipid nanoparticles for mRNA delivery.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2W 1R7
Reference Number:
172-2023-2024-Q2-1007835
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
714255304
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 68,000 dollars.
Amendment Date
Feb 19, 2025
Recipient's Operating Name:
ARN Technologies & Thérapeutiques
Recipient's Legal Name:
RNA Technologies & Therapeutics (RNA T&T) inc.
Federal Riding Name:
Laurier--Sainte-Marie
Federal Riding Number:
24039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: